Andrew C Braisted

Title: The Innovations of Andrew C. Braisted

Introduction

Andrew C. Braisted is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of peptides and their applications in medical science. With a total of 3 patents, Braisted's work has the potential to impact therapeutic strategies against viral infections.

Latest Patents

One of Braisted's latest patents is titled "Constrained helical peptides and methods of making same." This patent provides cyclized peptides with a constrained region having an α-helical conformation. These constrained helical peptides, which include amino acid sequences from HIV gp41, are designed for use in preparing antibodies that prevent viral membrane fusion. Additionally, Braisted has developed peptide variants of protein A, which are Z domain variants of staphylococcal protein A. These variants have a significantly reduced size while maintaining IgG-binding affinity equivalent to the wild type Z domain. They are suitable for use in affinity chromatography purification of proteins and in the treatment of staphylococcic diseases.

Career Highlights

Throughout his career, Andrew C. Braisted has worked with prominent companies in the biotechnology sector, including Genentech, Inc. and Sunesis Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in peptide technology.

Collaborations

Braisted has collaborated with esteemed colleagues such as Melissa A. Starovasnik and James A. Wells. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.

Conclusion

Andrew C. Braisted's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapeutic applications.